Search filters

List of works by Nicola Huxley

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients

scientific article published on 25 April 2015

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome

scientific article

A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer

scientific article

A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.

scientific article published on 8 December 2017

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England.

scientific article published in March 2018

Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation.

scientific article published in July 2017

Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model

scientific article

Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.

scientific article published in August 2016

Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS

scientific article published on 26 October 2014

Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.

scientific article published in September 2017

The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and e

scientific article

The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model

scientific article

The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome

scientific article published on 08 October 2019

What is the Clinical Effectiveness and Cost- Effectiveness of Erythropoietin-Stimulating Agents for the Treatment of Patients with Cancer-Treatment Induced Anaemia? Insights from Cumulative Meta-Analyses (CMA) and Lessons for Cost-Effectiveness Analy

scientific article published on 26 October 2014